Cargando…

Role of Surgery in Patients with Stage IE Primary Thyroid MALT Lymphoma Staged by a Modified Classification System: The Tokyo Classification

SIMPLE SUMMARY: The therapeutic strategy for and the staging system of primary thyroid mucosa-associated lymphoid tissue (MALT) lymphoma are not established. We conducted a retrospective analysis to (i) establish the appropriate staging system and (ii) assess the role of curative thyroidectomy vs. i...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Yoshiyuki, Watanabe, Natsuko, Suzuki, Nami, Saito, Naoko, Narimatsu, Hiroto, Takami, Hiroshi, Kameyama, Kaori, Yoshioka, Kana, Masaki, Chie, Akaishi, Junko, Hames, Kiyomi Yamada, Matsumoto, Masako, Fukushita, Miho, Yoshihara, Ai, Okamura, Ritsuko, Tomoda, Chisato, Suzuki, Akifumi, Matsuzu, Kenichi, Kitagawa, Wataru, Nagahama, Mitsuji, Noh, Jaeduk Yoshimura, Sugino, Kiminori, Ito, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000773/
https://www.ncbi.nlm.nih.gov/pubmed/36900242
http://dx.doi.org/10.3390/cancers15051451
_version_ 1784903963335720960
author Saito, Yoshiyuki
Watanabe, Natsuko
Suzuki, Nami
Saito, Naoko
Narimatsu, Hiroto
Takami, Hiroshi
Kameyama, Kaori
Yoshioka, Kana
Masaki, Chie
Akaishi, Junko
Hames, Kiyomi Yamada
Matsumoto, Masako
Fukushita, Miho
Yoshihara, Ai
Okamura, Ritsuko
Tomoda, Chisato
Suzuki, Akifumi
Matsuzu, Kenichi
Kitagawa, Wataru
Nagahama, Mitsuji
Noh, Jaeduk Yoshimura
Sugino, Kiminori
Ito, Koichi
author_facet Saito, Yoshiyuki
Watanabe, Natsuko
Suzuki, Nami
Saito, Naoko
Narimatsu, Hiroto
Takami, Hiroshi
Kameyama, Kaori
Yoshioka, Kana
Masaki, Chie
Akaishi, Junko
Hames, Kiyomi Yamada
Matsumoto, Masako
Fukushita, Miho
Yoshihara, Ai
Okamura, Ritsuko
Tomoda, Chisato
Suzuki, Akifumi
Matsuzu, Kenichi
Kitagawa, Wataru
Nagahama, Mitsuji
Noh, Jaeduk Yoshimura
Sugino, Kiminori
Ito, Koichi
author_sort Saito, Yoshiyuki
collection PubMed
description SIMPLE SUMMARY: The therapeutic strategy for and the staging system of primary thyroid mucosa-associated lymphoid tissue (MALT) lymphoma are not established. We conducted a retrospective analysis to (i) establish the appropriate staging system and (ii) assess the role of curative thyroidectomy vs. involved-site radiation therapy (ISRT) after open biopsy in stage IE MALT lymphoma. The modified staging system allows us to distinguish between stages IE and IIE primary thyroid MALT lymphoma. Information about the side effects under ISRT may have limited informative value, but approximately one in three to four patients had radiation-induced permanent complications (mainly dry mouth). Curative thyroidectomy provides good prognoses, equivalent to that of ISRT after open biopsy; it avoids permanent dry mouth, shortens painful periods during treatment, and simplifies ultrasound follow-ups. In the NCCN guidelines, ISRT is the preferred initial therapy for limited-stage non-gastric MALT lymphoma. However, curative thyroidectomy alone can serve as the initial treatment equivalent to ISRT post-open-biopsy. ABSTRACT: Purposes: To establish the appropriate staging system and assess the role of curative thyroidectomy alone (Surgery) vs. involved-site radiation therapy after open biopsy (OB-ISRT) in stage IE mucosa-associated lymphoid tissue (MALT) lymphoma. Methods: We examined the Tokyo Classification as a modified classification. This retrospective cohort study included 256 patients with thyroid MALT lymphoma; 137 underwent standard therapy (i.e., OB-ISRT) and were enrolled for the Tokyo classification. Sixty stage IE patients with the same diagnosis were examined to compare Surgery with OB-ISRT. Results: Overall survival (p = 0.0092) and relapse-free survival (0.00113) were significantly better in stage IE vs. stage IIE under the Tokyo classification. No OB-ISRT and Surgery patients died, but three OB-ISRT patients relapsed. The incidence of permanent complications was 28% in OB-ISRT (mainly dry mouth) and 0% in Surgery (p = 0.027). The number of painkiller prescription days was significantly greater in OB-ISRT (p < 0.001). During follow-up, the rate of the new appearance/change of the low-density area in the thyroid gland was significantly higher in OB-ISRT (p = 0.031). Conclusions: The Tokyo classification allows an appropriate discrimination between stages IE and IIE MALT lymphoma. Surgery can provide a good prognosis in stage IE cases; it also avoids complications, shortens painful periods during treatment, and simplifies ultrasound follow-up.
format Online
Article
Text
id pubmed-10000773
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100007732023-03-11 Role of Surgery in Patients with Stage IE Primary Thyroid MALT Lymphoma Staged by a Modified Classification System: The Tokyo Classification Saito, Yoshiyuki Watanabe, Natsuko Suzuki, Nami Saito, Naoko Narimatsu, Hiroto Takami, Hiroshi Kameyama, Kaori Yoshioka, Kana Masaki, Chie Akaishi, Junko Hames, Kiyomi Yamada Matsumoto, Masako Fukushita, Miho Yoshihara, Ai Okamura, Ritsuko Tomoda, Chisato Suzuki, Akifumi Matsuzu, Kenichi Kitagawa, Wataru Nagahama, Mitsuji Noh, Jaeduk Yoshimura Sugino, Kiminori Ito, Koichi Cancers (Basel) Article SIMPLE SUMMARY: The therapeutic strategy for and the staging system of primary thyroid mucosa-associated lymphoid tissue (MALT) lymphoma are not established. We conducted a retrospective analysis to (i) establish the appropriate staging system and (ii) assess the role of curative thyroidectomy vs. involved-site radiation therapy (ISRT) after open biopsy in stage IE MALT lymphoma. The modified staging system allows us to distinguish between stages IE and IIE primary thyroid MALT lymphoma. Information about the side effects under ISRT may have limited informative value, but approximately one in three to four patients had radiation-induced permanent complications (mainly dry mouth). Curative thyroidectomy provides good prognoses, equivalent to that of ISRT after open biopsy; it avoids permanent dry mouth, shortens painful periods during treatment, and simplifies ultrasound follow-ups. In the NCCN guidelines, ISRT is the preferred initial therapy for limited-stage non-gastric MALT lymphoma. However, curative thyroidectomy alone can serve as the initial treatment equivalent to ISRT post-open-biopsy. ABSTRACT: Purposes: To establish the appropriate staging system and assess the role of curative thyroidectomy alone (Surgery) vs. involved-site radiation therapy after open biopsy (OB-ISRT) in stage IE mucosa-associated lymphoid tissue (MALT) lymphoma. Methods: We examined the Tokyo Classification as a modified classification. This retrospective cohort study included 256 patients with thyroid MALT lymphoma; 137 underwent standard therapy (i.e., OB-ISRT) and were enrolled for the Tokyo classification. Sixty stage IE patients with the same diagnosis were examined to compare Surgery with OB-ISRT. Results: Overall survival (p = 0.0092) and relapse-free survival (0.00113) were significantly better in stage IE vs. stage IIE under the Tokyo classification. No OB-ISRT and Surgery patients died, but three OB-ISRT patients relapsed. The incidence of permanent complications was 28% in OB-ISRT (mainly dry mouth) and 0% in Surgery (p = 0.027). The number of painkiller prescription days was significantly greater in OB-ISRT (p < 0.001). During follow-up, the rate of the new appearance/change of the low-density area in the thyroid gland was significantly higher in OB-ISRT (p = 0.031). Conclusions: The Tokyo classification allows an appropriate discrimination between stages IE and IIE MALT lymphoma. Surgery can provide a good prognosis in stage IE cases; it also avoids complications, shortens painful periods during treatment, and simplifies ultrasound follow-up. MDPI 2023-02-24 /pmc/articles/PMC10000773/ /pubmed/36900242 http://dx.doi.org/10.3390/cancers15051451 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Saito, Yoshiyuki
Watanabe, Natsuko
Suzuki, Nami
Saito, Naoko
Narimatsu, Hiroto
Takami, Hiroshi
Kameyama, Kaori
Yoshioka, Kana
Masaki, Chie
Akaishi, Junko
Hames, Kiyomi Yamada
Matsumoto, Masako
Fukushita, Miho
Yoshihara, Ai
Okamura, Ritsuko
Tomoda, Chisato
Suzuki, Akifumi
Matsuzu, Kenichi
Kitagawa, Wataru
Nagahama, Mitsuji
Noh, Jaeduk Yoshimura
Sugino, Kiminori
Ito, Koichi
Role of Surgery in Patients with Stage IE Primary Thyroid MALT Lymphoma Staged by a Modified Classification System: The Tokyo Classification
title Role of Surgery in Patients with Stage IE Primary Thyroid MALT Lymphoma Staged by a Modified Classification System: The Tokyo Classification
title_full Role of Surgery in Patients with Stage IE Primary Thyroid MALT Lymphoma Staged by a Modified Classification System: The Tokyo Classification
title_fullStr Role of Surgery in Patients with Stage IE Primary Thyroid MALT Lymphoma Staged by a Modified Classification System: The Tokyo Classification
title_full_unstemmed Role of Surgery in Patients with Stage IE Primary Thyroid MALT Lymphoma Staged by a Modified Classification System: The Tokyo Classification
title_short Role of Surgery in Patients with Stage IE Primary Thyroid MALT Lymphoma Staged by a Modified Classification System: The Tokyo Classification
title_sort role of surgery in patients with stage ie primary thyroid malt lymphoma staged by a modified classification system: the tokyo classification
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000773/
https://www.ncbi.nlm.nih.gov/pubmed/36900242
http://dx.doi.org/10.3390/cancers15051451
work_keys_str_mv AT saitoyoshiyuki roleofsurgeryinpatientswithstageieprimarythyroidmaltlymphomastagedbyamodifiedclassificationsystemthetokyoclassification
AT watanabenatsuko roleofsurgeryinpatientswithstageieprimarythyroidmaltlymphomastagedbyamodifiedclassificationsystemthetokyoclassification
AT suzukinami roleofsurgeryinpatientswithstageieprimarythyroidmaltlymphomastagedbyamodifiedclassificationsystemthetokyoclassification
AT saitonaoko roleofsurgeryinpatientswithstageieprimarythyroidmaltlymphomastagedbyamodifiedclassificationsystemthetokyoclassification
AT narimatsuhiroto roleofsurgeryinpatientswithstageieprimarythyroidmaltlymphomastagedbyamodifiedclassificationsystemthetokyoclassification
AT takamihiroshi roleofsurgeryinpatientswithstageieprimarythyroidmaltlymphomastagedbyamodifiedclassificationsystemthetokyoclassification
AT kameyamakaori roleofsurgeryinpatientswithstageieprimarythyroidmaltlymphomastagedbyamodifiedclassificationsystemthetokyoclassification
AT yoshiokakana roleofsurgeryinpatientswithstageieprimarythyroidmaltlymphomastagedbyamodifiedclassificationsystemthetokyoclassification
AT masakichie roleofsurgeryinpatientswithstageieprimarythyroidmaltlymphomastagedbyamodifiedclassificationsystemthetokyoclassification
AT akaishijunko roleofsurgeryinpatientswithstageieprimarythyroidmaltlymphomastagedbyamodifiedclassificationsystemthetokyoclassification
AT hameskiyomiyamada roleofsurgeryinpatientswithstageieprimarythyroidmaltlymphomastagedbyamodifiedclassificationsystemthetokyoclassification
AT matsumotomasako roleofsurgeryinpatientswithstageieprimarythyroidmaltlymphomastagedbyamodifiedclassificationsystemthetokyoclassification
AT fukushitamiho roleofsurgeryinpatientswithstageieprimarythyroidmaltlymphomastagedbyamodifiedclassificationsystemthetokyoclassification
AT yoshiharaai roleofsurgeryinpatientswithstageieprimarythyroidmaltlymphomastagedbyamodifiedclassificationsystemthetokyoclassification
AT okamuraritsuko roleofsurgeryinpatientswithstageieprimarythyroidmaltlymphomastagedbyamodifiedclassificationsystemthetokyoclassification
AT tomodachisato roleofsurgeryinpatientswithstageieprimarythyroidmaltlymphomastagedbyamodifiedclassificationsystemthetokyoclassification
AT suzukiakifumi roleofsurgeryinpatientswithstageieprimarythyroidmaltlymphomastagedbyamodifiedclassificationsystemthetokyoclassification
AT matsuzukenichi roleofsurgeryinpatientswithstageieprimarythyroidmaltlymphomastagedbyamodifiedclassificationsystemthetokyoclassification
AT kitagawawataru roleofsurgeryinpatientswithstageieprimarythyroidmaltlymphomastagedbyamodifiedclassificationsystemthetokyoclassification
AT nagahamamitsuji roleofsurgeryinpatientswithstageieprimarythyroidmaltlymphomastagedbyamodifiedclassificationsystemthetokyoclassification
AT nohjaedukyoshimura roleofsurgeryinpatientswithstageieprimarythyroidmaltlymphomastagedbyamodifiedclassificationsystemthetokyoclassification
AT suginokiminori roleofsurgeryinpatientswithstageieprimarythyroidmaltlymphomastagedbyamodifiedclassificationsystemthetokyoclassification
AT itokoichi roleofsurgeryinpatientswithstageieprimarythyroidmaltlymphomastagedbyamodifiedclassificationsystemthetokyoclassification